These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19176200)

  • 1. Occult primary.
    Ettinger DS; Agulnik M; Cristea M; Eaton K; Fidias PM; Gockerman JP; Hameed O; Handorf C; Harris EI; Jacobs CD; Javle M; Khushalani NI; Kvols L; Lenzi R; Lewis NL; Rashid A; Saltz L; Shulman LN; Zager JS; Zhen W
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1026-60. PubMed ID: 19176200
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE issues guidance on cancer of unknown primary.
    MacReady N
    Lancet Oncol; 2010 Sep; 11(9):824. PubMed ID: 20842777
    [No Abstract]   [Full Text] [Related]  

  • 3. Occult primary cancer clinical practice guidelines.
    Ettinger DS; Arnoletti JP; Gockerman JP; Handorf C; Havlin KA; Jacobs CD; Javle M; Kvols L; Lenzi R; Rashid A; Rhoades CA; Ridge JA; Saltz L; Shulman LN; Sondak VK; Thompson JA; Twardowski P; Zhen W;
    J Natl Compr Canc Netw; 2005 Mar; 3(2):214-33. PubMed ID: 19817031
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult primary, version 3.2014.
    Ettinger DS; Handorf CR; Agulnik M; Bowles DW; Cates JM; Cristea M; Dotan E; Eaton KD; Fidias PM; Gierada D; Gilcrease GW; Godby K; Iyer R; Lenzi R; Phay J; Rashid A; Saltz L; Schwab RB; Shulman LN; Smerage JB; Stevenson MM; Varadhachary GR; Zager JS; Zhen WK; Bergman MA; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2014 Jul; 12(7):969-74. PubMed ID: 24994917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic occult primary cancer].
    Aabo K
    Ugeskr Laeger; 1987 Jan; 149(2):76-9. PubMed ID: 3544422
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and management of the unknown primary carcinoma of the head and neck.
    Galer CE; Kies MS
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1068-75. PubMed ID: 19176202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in unknown primary cancer.
    Culine S
    Semin Oncol; 2009 Feb; 36(1):60-4. PubMed ID: 19179189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of adenocarcinoma of unknown primary: are we making progress?
    Greco FA
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1061-7. PubMed ID: 19176201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic approach to cancer of unknown primary site].
    Fernández Cotarelo MJ; Guerra Vales JM
    Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of occult primary tumor with lymph node metastases in the area of the head and neck].
    Jungehülsing M; Eckel HE; Staar S; Ebeling O
    HNO; 1997 Jul; 45(7):573-83. PubMed ID: 9340343
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on the management of neuroendocrine hepatic metastases.
    Madoff DC; Gupta S; Ahrar K; Murthy R; Yao JC
    J Vasc Interv Radiol; 2006 Aug; 17(8):1235-49; quiz 1250. PubMed ID: 16923972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult primary malignancies.
    Yeomans AC; Washington JB
    Oncol Nurs Forum; 1991 Apr; 18(3):539-44. PubMed ID: 2057397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study.
    Sève P; Mackey J; Sawyer M; Lesimple T; de la Fouchardière C; Broussolle C; Dumontet C; Ray-Coquard I
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):658-9. PubMed ID: 18644703
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer with unknown primary--implementation of a regional referral process and clinical practice guidelines.
    Randén M; Lewin F; Helde Frankling M; Johansson H; Lagerros C; Rutqvist LE
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):564. PubMed ID: 18501570
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer from an unknown primary site.
    Dowell JE
    Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of unknown primary site.
    Guntinas-Lichius O
    N Engl J Med; 2014 Nov; 371(21):2039-40. PubMed ID: 25409388
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoma of unknown primary site.
    Jain A; Tan TJ; Tan DS
    N Engl J Med; 2014 Nov; 371(21):2039. PubMed ID: 25409387
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoma of unknown primary site.
    Varadhachary GR; Raber MN
    N Engl J Med; 2014 Nov; 371(21):2040. PubMed ID: 25409386
    [No Abstract]   [Full Text] [Related]  

  • 20. Occult cancer in older patients presenting with venous thromboembolism.
    Kelly J; Rudd T; Lewis R; Hunt B
    Age Ageing; 2002 Mar; 31(2):101-4. PubMed ID: 11937473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.